Biologics

Illustration showing how Xolair (omalizumab) treats allergic bronchopulmonary aspergillosis (ABPA) by blocking IgE antibodies and reducing allergic inflammation in the lungs.

Why Can an Asthma Drug Help ABPA? Understanding Xolair (Omalizumab)

Patient considering different causes of worsening respiratory symptoms while receiving omalizumab treatment, including ABPA, bronchiectasis, chest infection and mucus plugging.

Has My Omalizumab Stopped Working? Understanding Worsening Symptoms, Infections and Flare-Ups in Asthma and ABPA

Patient with Allergic Bronchopulmonary Aspergillosis (ABPA) considering biologic treatment, alongside an infographic explaining why steroids and antifungal medicines are often used before biologics.

Why Do People With ABPA Usually Have to Try Steroids and Antifungals Before Biologics?

Last reviewed: June 2026…

🧬 How Biologics Are Reshaping Our Understanding of ABPA Subtypes

For many years, Allergic…

Depemokimab – a new long-acting treatment for severe asthma: what aspergillosis patients need to know

A new medicine called…

🌿 Biologics when ABPA and CPA overlap: What Patients Need to Know

Understanding how they work,…

Side effects from Biologic Medication

It’s completely…

🌿 Your Immune System, Biologics, and Steroids: What’s Suppressed — and What Stays Strong

A clear, reassuring guide for…

🌿 ABPA: Infection, Allergy, Biologics, and What It All Means for You

A calm, supportive guide for…

🌟 Biologics and the Future: A Toolkit for Severe Asthma, ABPA & Beyond

Many people with severe…